PolicyBrief
H.RES. 345
119th CongressApr 24th 2025
Expressing support for designation of the month of April 2025 as "Parkinsons Awareness Month".
IN COMMITTEE

This resolution expresses Congressional support for designating April 2025 as Parkinson's Awareness Month to promote research, education, and support for those affected by the disease.

Wesley Bell
D

Wesley Bell

Representative

MO-1

LEGISLATION

Congress Backs Parkinson's Awareness: Resolution Highlights $80 Billion Future Cost and Research Needs

This resolution is Congress’s way of formally recognizing the seriousness of Parkinson’s disease (PD) by designating April 2025 as “Parkinson’s Awareness Month.” Essentially, it’s a non-binding but highly supportive statement aimed at raising visibility for a condition that is rapidly becoming a major public health and economic issue in the U.S.

The Growing Burden of Parkinson's

If you think this is just a symbolic gesture, check the numbers the resolution cites. Over a million Americans are currently living with Parkinson’s, and that number is expected to nearly double by 2037. The resolution points out that this growth comes with a staggering price tag: the annual cost to the nation is projected to hit at least $80 billion. For those of us juggling rising healthcare costs, this is a signal that the economic strain of neurological diseases is a runaway train we need to get ahead of. This isn't just about patients; it's about the financial stability of our healthcare systems and the millions of family caregivers shouldering the burden now.

More Than Just a Designation

While the main action is naming April as Awareness Month, the core of the resolution is a strong call for action. Congress officially states its support for continued research to find better treatments and, ultimately, a cure. They are also backing the need for better education and community support services. This is crucial because PD doesn't just cause physical symptoms like tremors and movement issues; it often involves serious quality-of-life impacts like dementia, depression, and speech difficulty. Supporting these services means supporting the dignity of those living with the disease.

Recognizing the Real MVPs

The resolution also takes a moment to commend the people doing the heavy lifting. It specifically recognizes the patients who participate in clinical trials—the unsung heroes risking their time and health to help advance science. It also praises the millions of dedicated family caregivers, volunteers, and organizations working daily to improve the lives of those affected. While this resolution doesn't cut a check or pass a new law, it sends a clear signal that Congress views Parkinson's research and awareness as a priority. For researchers fighting for grants or organizations trying to secure funding, this high-level recognition is a valuable tool to validate their critical work.